title: [Application of fibrinolysis inhibitor tranexam in transurethral resection of the prostate].
abstract: Prostatic surgery is often accompanied with increased intra- and postoperative bleeding which is caused, among other reasons, by enhancement of general and local fibrinolysis due to mechanical impact on prostatic tissue in operation. We proposed to inhibit enhanced fibrinolysis with preparation of tranexamic acid tranexam and tried it in 53 patients with prostatic adenoma undergoing transurethral prostatic resection (TUR). The comparison of bleeding severity in surgery with and without tranexam administration before, in and early after prostatic TUR showed that tranexam significantly lowers blood loss.
authors.forename: S Kh
authors.initials: SKh
authors.lastname: Al'-Shukri
authors.forename: E T
authors.initials: ET
authors.lastname: Goloshchapov
authors.forename: G B
authors.initials: GB
authors.lastname: Lukichev
mesh_terms: D000368:Aged; D000933:Antifibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D011470:Prostatic Hyperplasia / Q000601:surgery*; D014148:Tranexamic Acid / Q000008:administration & dosage*; D020728:Transurethral Resection of Prostate
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid